S. Bella

Irinotecan, Oxaliplatin Plus Bolus 5-Fluorouracil and Low Dose Folinic Acid Every 2 Weeks: A Feasibility Study in Metastatic Colorectal Cancer Patients

E. Richardet, F. Cóppola, Claudio Martín, 2006, American journal of clinical oncology.

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective

F. Schutz, N. Shore, C. Martínez, 2018, Medical Oncology.

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.

M. Vilanova, E. Cazap, G. Recondo, 2001, European journal of cancer.

Multidisciplinary approach to COVID-19 and cancer: consensus from scientific societies in Argentina

E. Smecuol, F. Nachman, S. Quildrian, 2020, Ecancermedicalscience.